News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

LI-COR Biosciences Licenses Prostate-Targeting Molecular Imaging Agent from Johns Hopkins University


9/9/2011 10:38:31 AM

LINCOLN, Neb.--(BUSINESS WIRE)--LI-COR Biosciences has entered into a licensing agreement with The Johns Hopkins University (Baltimore, MD) for compounds and imaging methods targeting prostate-specific membrane antigen (PSMA) developed in the laboratory of Dr. Martin Pomper. As an enzyme with an extracellular active site, PSMA represents an excellent target for imaging and therapy directed toward solid tumor neovasculature in addition to prostate cancer itself.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES